- Home
- SPTN vs SVRA Comparison
SPTN vs SVRA Comparison
Compare SPTN & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPTN
- SVRA
- Stock Information
- Founded
- SPTN 1917
- SVRA N/A
- Country
- SPTN United States
- SVRA United States
- Employees
- SPTN N/A
- SVRA N/A
- Industry
- SPTN Food Distributors
- SVRA Biotechnology: Pharmaceutical Preparations
- Sector
- SPTN Consumer Discretionary
- SVRA Health Care
- Exchange
- SPTN Nasdaq
- SVRA Nasdaq
- Market Cap
- SPTN 686.2M
- SVRA 446.2M
- IPO Year
- SPTN N/A
- SVRA N/A
- Fundamental
- Price
- SPTN $19.94
- SVRA $2.76
- Analyst Decision
- SPTN Hold
- SVRA Buy
- Analyst Count
- SPTN 1
- SVRA 6
- Target Price
- SPTN $20.00
- SVRA $8.83
- AVG Volume (30 Days)
- SPTN 287.3K
- SVRA 915.6K
- Earning Date
- SPTN 02-12-2025
- SVRA 05-08-2025
- Dividend Yield
- SPTN 4.39%
- SVRA N/A
- EPS Growth
- SPTN N/A
- SVRA N/A
- EPS
- SPTN 0.01
- SVRA N/A
- Revenue
- SPTN $9,549,324,000.00
- SVRA N/A
- Revenue This Year
- SPTN $5.82
- SVRA N/A
- Revenue Next Year
- SPTN N/A
- SVRA N/A
- P/E Ratio
- SPTN $2,236.50
- SVRA N/A
- Revenue Growth
- SPTN N/A
- SVRA N/A
- 52 Week Low
- SPTN $17.30
- SVRA $2.26
- 52 Week High
- SPTN $23.00
- SVRA $5.34
- Technical
- Relative Strength Index (RSI)
- SPTN 53.72
- SVRA 55.10
- Support Level
- SPTN $19.64
- SVRA $2.50
- Resistance Level
- SPTN $20.66
- SVRA $2.72
- Average True Range (ATR)
- SPTN 0.47
- SVRA 0.17
- MACD
- SPTN -0.06
- SVRA 0.03
- Stochastic Oscillator
- SPTN 47.45
- SVRA 75.94
About SPTN SpartanNash Company
SpartanNash Co is a food solutions company that delivers the ingredients. Its principal business activities include, distributing grocery products to a diverse group of independent and chain retailers, its corporate-owned retail stores, and U.S. military commissaries and exchanges; as well as operating a fresh produce distribution network and the Our Family private label brand. The company operates in two segments: Retail and Wholesale. Majority of the revenue is earned from its Wholesale segment which uses a multi-channel sales approach to distribute national brand and private brand products to independent retailers, national accounts, food service distributors, e-commerce providers, and the Company's corporate owned retail stores.
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.